BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Teva
QuintilesIMS
Merck
Julphar
Cerilliant
Healthtrust
McKinsey
Farmers Insurance
Queensland Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018657

« Back to Dashboard

NDA 018657 describes FLAGYL I.V. RTU IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and Pfizer and is included in two NDAs. It is available from one supplier. Additional details are available on the FLAGYL I.V. RTU IN PLASTIC CONTAINER profile page.

The generic ingredient in FLAGYL I.V. RTU IN PLASTIC CONTAINER is metronidazole. There are eighteen drug master file entries for this compound. Eighty-five suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 018657
Tradename:FLAGYL I.V. RTU IN PLASTIC CONTAINER
Applicant:Baxter Hlthcare
Ingredient:metronidazole
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 018657
Ingredient-typeNitroimidazoles
Medical Subject Heading (MeSH) Categories for 018657
Suppliers and Packaging for NDA: 018657
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLAGYL I.V. RTU IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 018657 NDA Baxter Healthcare Corporation 0338-1055 0338-1055-48 24 BAG in 1 CARTON (0338-1055-48) > 100 mL in 1 BAG
FLAGYL I.V. RTU IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 018657 NDA Baxter Healthcare Corporation 0338-9541 0338-9541-24 24 BAG in 1 CARTON (0338-9541-24) > 100 mL in 1 BAG

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Mallinckrodt
Express Scripts
UBS
Federal Trade Commission
Baxter
Daiichi Sankyo
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot